BWX Technologies Reports Second Quarter 2026 Results

2Q26 revenues of $901.6 million

2Q26 net income of $89.1 million, adjusted EBITDA(1) of $155.5 million

2Q26 diluted GAAP EPS of $0.97, non-GAAP(1) EPS of $1.07

Announced the sale of the medical business, enabling increased focus on core nuclear national defense and commercial nuclear power markets